Integrated BioPharma, Inc.'s Plant-Produced Flu Subunit Vaccines Provide Protection in Preclinical Studies

HILLSIDE, N.J., April 30, 2008 (PRIME NEWSWIRE) -- InB:Biotechnologies, Inc., a wholly-owned subsidiary of Integrated BioPharma, Inc. (Nasdaq:INBP), announced today that prototypes of the Company's influenza subunit vaccines provided complete protection against infection in the ferret challenge model and proved highly immunogenic in a mouse model. The ferret model is the industry standard for studying influenza infections and for testing flu vaccine candidates.

Back to news